Discontinue Zyprexa 20 mg Now That Patient Is Calm
Since the patient is now calm after receiving olanzapine 20 mg for agitation following diphenhydramine overdose, you should discontinue the olanzapine immediately. The medication served its acute purpose, and continuing it poses unnecessary risks in this toxicologic context.
Critical Context: Anticholinergic Toxicity
The agitation was secondary to diphenhydramine (Benadryl) overdose, which causes anticholinergic toxicity. This is a crucial detail because:
- Antipsychotics like olanzapine can paradoxically worsen agitation in anticholinergic poisoning due to their own anticholinergic properties 1
- The guidelines explicitly warn: "agitation may be a result of drug ingestions or poisonings with anticholinergic or sympathomimetic agents. In this scenario, the antipsychotics, both conventional and atypical...can potentially exacerbate agitation because of their anticholinergic side effects" 1
Why Discontinue Now
The patient achieved the therapeutic goal—they are calm. Olanzapine was appropriately used for acute behavioral control, but there is no indication to continue it:
- Olanzapine 20 mg is effective for acute agitation with rapid onset 2, 3, 4
- Once agitation resolves, continuing antipsychotics in toxicologic cases adds risk without benefit
- The underlying cause (diphenhydramine toxicity) will resolve with supportive care and time
Monitoring Going Forward
Observe the patient closely as diphenhydramine effects wear off:
- Anticholinergic toxicity symptoms should improve over 12-24 hours with supportive care
- If agitation recurs, benzodiazepines (lorazepam 1-2 mg) are preferred over additional antipsychotics in this toxicologic context 1
- Benzodiazepines lack anticholinergic properties and won't worsen the underlying toxidrome
Common Pitfall to Avoid
Do not continue olanzapine "just in case" or transition to scheduled dosing. This patient doesn't have a primary psychiatric disorder requiring ongoing antipsychotic therapy—they had drug-induced agitation that has now resolved. The FDA label notes olanzapine overdose itself can cause agitation, delirium, and CNS depression 5, making continued use particularly problematic in this overdose scenario.
If the patient remains calm, no further antipsychotic dosing is needed. Focus on supportive care for the diphenhydramine overdose and monitoring for symptom resolution.